Delivery Order SPE2D018D0006-SPE2D325F7998
Award Date
3/13/25
Potential Completion Date
3/18/25
Potential Value
$16K
Federal Agency
Medical Supply Chain
Awardee
Eagle Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2D018D0006|SPE2D021F0173 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The $87,282.92 firm fixed-price delivery order contract is for the provision of other medical supplies, specifically the 250mg injectable medication Ryanodex, used to treat and prevent malignant hyperthermia in high-risk patients. This contract does not have a set-aside designation, indicating Eagle Pharmaceuticals...
This federal contract award, valued at $10,585.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250mg vials. Ryanodex is a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a delivery order with a firm fixed-price pricing type and a performance period ending on January 29, 2025. This award is not associated with a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a ceiling value of $5,292.66 and a period of performance through February 10, 2025. Eagle Pharmaceuticals is the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used to treat and prevent malignant hyperthermia in high-risk patients. The contract has a ceiling value of $5,080.62 and an ultimate completion date of December 10, 2024. This contract is not associated with any set-aside...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
Eagle Pharmaceuticals, Inc. has been awarded a $4,874.13 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 250mg vials of the drug Ryanodex. As the prime contractor, Eagle Pharmaceuticals will deliver the specified pharmaceutical products to DLA Troop Support Medical's place of performance in Westwood, New Jersey by November 15, 2023. No major subcontractors or joint venture partners are involved. The delivery order was...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,632.64, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, valued at $4,816.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a specific medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 21, 2025. The contract award is not designated with a set-aside requirement, indicating an...
This federal contract award, valued at $16,386.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a completion date of November 8, 2024. The award is not associated with a set-aside program and is a firm-fixed-price delivery order contract. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $8,996.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a period of performance through March 5, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...